CLINICAL_TRIALS
trial_result
· 2011-10-26
Clinical Trial Update: Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)
Summary
A completed clinical trial update reports a program extension of real-life dosing of Remicade (infliximab) in Austria for Crohn's disease, with results posted i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn's Disease | Status: COMPLETED | Results posted: 2011-10-26